Compare ANTX & OCAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANTX | OCAC |
|---|---|---|
| Founded | 2017 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.9M | 156.2M |
| IPO Year | 2022 | 2022 |
| Metric | ANTX | OCAC |
|---|---|---|
| Price | $3.36 | $9.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 321.9K | 33.3K |
| Earning Date | 11-11-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $9.86 |
| 52 Week High | $7.19 | $10.05 |
| Indicator | ANTX | OCAC |
|---|---|---|
| Relative Strength Index (RSI) | 22.69 | 60.65 |
| Support Level | $2.87 | $9.94 |
| Resistance Level | $5.21 | N/A |
| Average True Range (ATR) | 0.41 | 0.02 |
| MACD | -0.18 | -0.00 |
| Stochastic Oscillator | 2.23 | 22.22 |
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
Ocean Capital Acquisition Corp is a blank check company.